My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    Immunol Res. 2006;36(1-3):73-82.

    Human tumor antigens, immunosurveillance, and cancer vaccines.

    Finn OJ.

    Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. ojfinn@pitt.edu

    Abstract

    Cancer is a serious health problem as well as a scientific challenge. A lot has been learned about the process of transformation of a normal cell into a tumor cell by studying genes and proteins that regulate this process either in cis or in trans. However, whether these molecular mechanisms succeed in fulfilling their potential to give a clinically evident disease depends in great measure on the host response to those molecular changes. The work of my laboratory aims to provide evidence in animal models as well as in cancer patients that immune system can control cancer growth and that this important function can be improved through vaccination with well-defined tumor antigens.

    PMID: 17337768 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Write to the Help Desk